Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Shrivastava, T. Bera, A. Roy, G. Singh, P. Ramachandrarao, Debabrata Dash (2007)
Characterization of enhanced antibacterial effects of novel silver nanoparticlesNanotechnology, 18
Jong Kim (2007)
Reduction of Silver Nitrate in Ethanol by Poly(N-vinylpyrrolidone)Journal of Industrial and Engineering Chemistry, 13
Subhash Singh, A. Sehgal, Sa Waghmare, T. Chakraborty, A. Goswami, Shobhona Sharma (2002)
Surface expression of the conserved ribosomal protein P0 on parasite and other cells.Molecular and biochemical parasitology, 119 1
Ayesha Rahman, D. Seth, S. Mukhopadhyaya, R. Brahmachary, C. Ulrichs, A. Goswami (2008)
Surface functionalized amorphous nanosilica and microsilica with nanopores as promising tools in biomedicineNaturwissenschaften, 96
J. Elechiguerra, Justin Burt, J. Morones, A. Camacho-Bragado, Xiaoxia Gao, Humberto Lara, Miguel Yacaman (2005)
Interaction of silver nanoparticles with HIV-1Journal of Nanobiotechnology, 3
F. Furno, Kelly Morley, Ben Wong, B. Sharp, P. Arnold, S. Howdle, R. Bayston, P. Brown, P. Winship, H. Reid (2004)
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?The Journal of antimicrobial chemotherapy, 54 6
Shobhona Sharma, S. Deodhar, Nevil Singh, L. Kabilan, A. Goswami (1996)
Immunogenicity of the nonrepetitive regions of the circumsporozoite protein of Plasmodium knowlesi.The American journal of tropical medicine and hygiene, 55 6
(1950)
Harrison's Principles of Internal Medicine
C. Ulrichs, B. Welke, T. Mucha-Pelzer, A. Goswami, I. Mewis (2008)
Effect of Solid Particulate Matter Deposits on Vegetation - A Review
(2003)
Treatment of tuberculosis: guidelines for national programmes
D. Bandyopadhyay, S. Gupta, S. Banerjee, D. Ray, S. Bhattacharya, B. Bhattacharya (2008)
Adenosine deaminase estimation and multiplex polymerase chain reaction in diagnosis of extra-pulmonary tuberculosis.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 12 10
M. Pearson, J. Jereb, T. Frieden, J. Crawford, B. Davis, S. Dooley, W. Jarvis (1992)
Nosocomial Transmission of Multidrug-resistant Mycobacterium tuberculosisAnnals of Internal Medicine, 117
B Wan, A Rayner, G Harris (2006)
Mackie & Mc Cartney’s practical medical microbiology
SW Dooley, WR Jarvis, WJ Martone, DE Snyder (1992)
Multidrug resistant tuberculosis (editorial)Ann Intern Med, 117
S. Dooley, W. Jarvis, William Marione, D. Snider (1992)
Multidrug-resistant TuberculosisAnnals of Internal Medicine, 117
(2004)
Baily & Scott’s diagnostic microbiology
K. Ariga (2009)
A Special Issue on : Advanced Materials for Nanoscience and NanotechnologyJournal of Nanoscience and Nanotechnology, 9
Ayesha Rahman, Nupur Biswas, C. Ulrichs, C. Büttner, R. Bramhachary, A. Goswami, A. Datta (2009)
Nanoparticle-virus complex shows enhanced immunological effect against baculovirus.Journal of nanoscience and nanotechnology, 9 9
Xiao Chen, H. Schluesener (2008)
Nanosilver: a nanoproduct in medical application.Toxicology letters, 176 1
G. Kubica, W. Dye, M. Cohn, G. Middlebrook (2015)
Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria.The American review of respiratory disease, 87
A. Goswami, Subhash Singh, V. Redkar, Shobhona Sharma (1997)
Characterization of P0, a ribosomal phosphoprotein of Plasmodium falciparum. Antibody against amino-terminal domain inhibits parasite growth.The Journal of biological chemistry, 272 18
V. Sritharan, R. Barker (1991)
A simple method for diagnosing M. tuberculosis infection in clinical samples using PCR.Molecular and cellular probes, 5 5
Peter Barnes, Alan Bloch, Paul Davidson, Dixie Snider (1991)
Tuberculosis in patients with human immunodeficiency virus infection.The New England journal of medicine, 324 23
A. Goswami, S. Chatterjee, S. Sharma (1996)
Cloning of a ribosomal phosphoprotein P0 gene homologue from Plasmodium falciparum.Molecular and biochemical parasitology, 82 1
Despite discovery of the pathogen more than 100 years ago, tuberculosis (TB) continues to be a major killer disease worldwide. Currently a third of world population is infected and multiple-drug-resistant (mdr) TB registers maximum mortality by a single pathogen. Nanomedicine provides enormous opportunity for developing novel drugs. We have recently demonstrated surface-modified-lipophilic-nanosilica as drug to combat malaria and 100% lethal virus, BmNPV. Nanosilver possesses inherent antibacterial properties, but toxicity is a major concern. We hypothesized that capping with nature-inspired biomolecules, bovine serum albumin (BSA) and Poly-n-vinyl-pyrrolidone (PVP) used as blood volume extender, might insure biosafety. BSA-nano-Ag was found to be more stable than PVP-nano-Ag at physiological pH. In this first ever study on clinical isolates collected from TB endemic areas, we report, BSA-nano-Ag act as potent anti-TB drug. Further study with (human serum albumin)-nano-Ag and core–shell-nano-Ag could increase the biocompatibility of oral TB drug formulations without compromising on the efficacy of the drug.
Current Microbiology – Springer Journals
Published: Oct 10, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.